Basel Medical Group Ltd Ordinary Shares (BMGL) Financials

$0.76

$0.1 (-11.24%)
Last update: 04:00 PM EST
Day's range
$0.75
Day's range
$0.85

BMGL Income statement / Annual

Last year (2024), Basel Medical Group Ltd Ordinary Shares's total revenue was $11.32 M, an increase of 12.63% from the previous year. In 2024, Basel Medical Group Ltd Ordinary Shares's net income was -$12.09 M. See Basel Medical Group Ltd Ordinary Shares,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021
Period Ended 06/30/2025 06/30/2024 06/30/2023 06/30/2022
Operating Revenue $11.32 M $10.05 M $9.70 M $10.66 M
Cost of Revenue $2.53 M $2.25 M $2.34 M $2.18 M
Gross Profit $8.79 M $7.80 M $7.36 M $8.48 M
Gross Profit Ratio 0.78 0.78 0.76 0.8
Research and Development Expenses $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $6.54 M $3.64 M $3.27 M $4.04 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.54 M $3.64 M $3.27 M $4.04 M
Other Expenses $4.44 M $1.97 M $2.10 M $1.96 M
Operating Expenses $10.98 M $5.61 M $5.36 M $6.01 M
Cost And Expenses $13.50 M $7.86 M $7.70 M $8.18 M
Interest Income $83.27 K $0.00 $295.59 K $246.71 K
Interest Expense $203.95 K $176.24 K $238.60 K $320.87 K
Depreciation & Amortization $1.18 M $528.73 K $557.13 K $575.92 K
EBITDA -$11.12 M $3.11 M $2.93 M $3.28 M
EBITDA Ratio -0.98 0.31 0.3 0.31
Operating Income Ratio -0.19 0.22 0.21 0.23
Total Other Income/Expenses Net -$10.32 M $209.45 K $128.65 K -$87.75 K
Income Before Tax -$12.51 M $2.40 M $2.13 M $2.39 M
Income Before Tax Ratio -1.1 0.24 0.22 0.22
Income Tax Expense -$417.39 K $331.76 K $348.28 K $408.48 K
Net Income -$12.09 M $2.07 M $1.78 M $1.98 M
Net Income Ratio -1.07 0.21 0.18 0.19
EPS 0 0.11 0.0951 0.11
EPS Diluted 0 0.11 0.0951 0.11
Weighted Average Shares Out $0.00 $18.75 M $18.75 M $18.75 M
Weighted Average Shares Out Diluted $0.00 $18.75 M $18.75 M $18.75 M
Link